Novo Nordisk Wins FDA Approval for Weight-Loss Pill, Alphabet Buys Clean Energy Provider
The Rundown
00:00
Johnson & Johnson Talc Verdict
Zaid explains a jury's $1.5B mesothelioma award and J&J's denial and immediate appeal plans.
Play episode from 07:09
Transcript
